1. Home
  2. NOAH vs CDNA Comparison

NOAH vs CDNA Comparison

Compare NOAH & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOAH
  • CDNA
  • Stock Information
  • Founded
  • NOAH 2005
  • CDNA 1998
  • Country
  • NOAH China
  • CDNA United States
  • Employees
  • NOAH N/A
  • CDNA N/A
  • Industry
  • NOAH Investment Managers
  • CDNA Medical Specialities
  • Sector
  • NOAH Finance
  • CDNA Health Care
  • Exchange
  • NOAH Nasdaq
  • CDNA Nasdaq
  • Market Cap
  • NOAH 805.9M
  • CDNA 712.2M
  • IPO Year
  • NOAH 2010
  • CDNA 2014
  • Fundamental
  • Price
  • NOAH $12.08
  • CDNA $13.10
  • Analyst Decision
  • NOAH Buy
  • CDNA Buy
  • Analyst Count
  • NOAH 2
  • CDNA 6
  • Target Price
  • NOAH $12.25
  • CDNA $29.33
  • AVG Volume (30 Days)
  • NOAH 76.1K
  • CDNA 2.3M
  • Earning Date
  • NOAH 08-27-2025
  • CDNA 08-06-2025
  • Dividend Yield
  • NOAH 4.79%
  • CDNA N/A
  • EPS Growth
  • NOAH N/A
  • CDNA N/A
  • EPS
  • NOAH 0.96
  • CDNA 1.07
  • Revenue
  • NOAH $353,619,651.00
  • CDNA $346,421,000.00
  • Revenue This Year
  • NOAH N/A
  • CDNA $12.81
  • Revenue Next Year
  • NOAH $6.50
  • CDNA $13.36
  • P/E Ratio
  • NOAH $12.57
  • CDNA $12.19
  • Revenue Growth
  • NOAH N/A
  • CDNA 25.92
  • 52 Week Low
  • NOAH $7.33
  • CDNA $10.96
  • 52 Week High
  • NOAH $14.90
  • CDNA $34.84
  • Technical
  • Relative Strength Index (RSI)
  • NOAH 50.95
  • CDNA 36.77
  • Support Level
  • NOAH $11.69
  • CDNA $11.94
  • Resistance Level
  • NOAH $12.33
  • CDNA $13.29
  • Average True Range (ATR)
  • NOAH 0.29
  • CDNA 0.65
  • MACD
  • NOAH -0.07
  • CDNA 0.04
  • Stochastic Oscillator
  • NOAH 42.86
  • CDNA 83.15

About NOAH Noah Holdings Limited

Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: